Pain Killer, Anxiety and Mucogingival Therapy

Study Overview
=================
Brief Summary
-----------------
Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?

Detailed Description
-----------------
Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention. Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy . This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.

Official Title
-----------------
Is Pain Killer Cunsumption Dependent to Anxiety or Mucogingival Therapy?

Conditions
-----------------
Anxiety and Depression

Intervention / Treatment
-----------------
* Procedure: gingival graft


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ASA type I and II subjects Localized Gingival Recessions Recessions Cairo RT I-II FMPS < 10% FMBS< 10% <10 cigs/ day No contra-indication against oral surgical interventions Patient is able to give inform consent Exclusion Criteria: Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests. ASA type > II Current pregnancy or breastfeeding women Alcoholism or chronically drug abuse Smokers, ≳ 10 cigarettes per day Immunocompromised patients Uncontrolled diabetes Untreated periodontitis History of previous periodontal surgery (mucogingival or other) on the teeth to be included Presence of severe tooth malposition, rotation or significant version of the tooth to be treated

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Allocation: Randomized
Intervention Model: Crossover Assignment
Interventional Model Description: group test free gingival graft group control connective tissue graft
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Control group: free gingival graft for gingival recession<br> | Procedure: gingival graft<br>* investigators: Donor site: tissue graft harvesting from the palate behind the palatal rugae . placement of a palatine hemostatic plaque on the palate in order to reduce the risk of bleeding and to diminish the postoperative pain. Received site: Control: the horizontal incision adjacent to the recession(s) and vertical incisions and split thickness flap. Placement of the graft on the recipient bed and suture. Test :connective tissue graft using the  envelope/pouch  technique with two partial thickness incisions (deep and superficial). Placement of the graft inside the envelope<br>|
| Experimental: Test group: connective tissue graft for gingival recession<br> | Procedure: gingival graft<br>* investigators: Donor site: tissue graft harvesting from the palate behind the palatal rugae . placement of a palatine hemostatic plaque on the palate in order to reduce the risk of bleeding and to diminish the postoperative pain. Received site: Control: the horizontal incision adjacent to the recession(s) and vertical incisions and split thickness flap. Placement of the graft on the recipient bed and suture. Test :connective tissue graft using the  envelope/pouch  technique with two partial thickness incisions (deep and superficial). Placement of the graft inside the envelope<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| pin killer consumption | the number of pain killer used after treatment | two weeks |